Your browser is unsupported

We recommend using the latest version of IE11, Edge, Chrome, Firefox or Safari.

In this section

2014

The RxPress is the bimonthly newsletter from the University of Illinois Hospital and Health Sciences System Pharmacy Department.

Nov-Dec 2014 edition

  • New Labeling System for Pregnancy and Lactation 
  • Changes in Medical Errors After Implementation of a Handoff Program
  • Risk of Bleeding with Warfarin versus Dabigatran

Sep-Oct 2014 edition

  • 2014 Skin and Soft Tisse Infection Guidelines     
  • Safe Use of Opioids  
  • Pediatric Adverse Events

Jul-August 2014 edition

  • Effects of Niacin on Cardiovascular Risk      
  • Standardized Units Recommendation      
  • Viscous Lidocaine Warning      
  • Vial Safety   

May-June 2014 edition       

  • Middle East Respiratory Syndrome Coronavirus      
  • Dabigatran and Risk of Bleeding--An Update from the FDA      
  • Medication Safety and Nonadherence        

Mar-April 2014 edition

  • Increased Risk of Death with Doripenem Used for Ventilator-associated Pneumonia      
  • Improved Mortality with ACE Inhibitors but not ARBs in Diabetes      
  • Two New Atrial Fibrillation Guidelines Incorportate New Risk Staging System and   Anticoagulants 
  • Benefits of Neuraminidase Inhibitors Questioned by Meta-analysis   

Jan-February 2014 edition

  • Immune globulins and the risk for thrombotic events      
  • Upcoming changes to the pregnancy labeling of drugs      
  • Key features of the new hypertension treatment guidelines
Top